WAM
ANIP icon

Wealthspire Advisors (Maryland)’s ANI Pharmaceuticals ANIP Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-37
Closed -$3K – 539
2019
Q1 		$3K Hold
37
– – ﹤0.01% 1967
2018
Q4 		$2K Hold
37
– – ﹤0.01% 2048
2018
Q3 		$2K Hold
37
– – ﹤0.01% 2124
2018
Q2 		$2K Hold
37
– – ﹤0.01% 2117
2018
Q1 		$2K Sell
37
-2
-5% -$127 ﹤0.01% 2128
2017
Q4 		$3K Buy
39
+37
+1,850% +$2.3K ﹤0.01% 1965
2017
Q3 		$0 Buy
+2
New +$95 ﹤0.01% 2242

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s ANIP Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of ANI Pharmaceuticals (ANIP) in Q2 2019, closing a stake of 37 shares — an estimated $3K sold.

Wealthspire Advisors (Maryland) first reported a position in ANIP in Q3 2017 and held it in 7 quarters. The position peaked at $3K in Q1 2019. 196 funds tracked by Wall St. Rank hold ANIP as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining ANI Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 37 ANI Pharmaceuticals shares in Q2 2019, an estimated $3K.
  • Wealthspire Advisors (Maryland) first reported a position in ANI Pharmaceuticals in Q3 2017 and held it in 7 quarters.
  • Wealthspire Advisors (Maryland)'s ANI Pharmaceuticals position peaked at $3K in Q1 2019.
  • 196 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.